General Information of the Compound
| Compound ID |
CP0421056
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(1S)-1-[3-[4-(4-phenylmethoxyphenoxy)phenyl]-1,2,4-oxadiazol-5-yl]ethyl]acetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H23N3O4
|
||||||||||||||||||
| Molecular Weight |
429.476
|
||||||||||||||||||
| Canonical SMILES |
C[C@H](NC(C)=O)c1nc(no1)-c1ccc(Oc2ccc(OCc3ccccc3)cc2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H23N3O4/c1-17(26-18(2)29)25-27-24(28-32-25)20-8-10-22(11-9-20)31-23-14-12-21(13-15-23)30-16-19-6-4-3-5-7-19/h3-15,17H,16H2,1-2H3,(H,26,29)/t17-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
VQKAKICSSLMPRX-KRWDZBQOSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00910, Peroxisome proliferator-activated receptor alpha
Protein ID: PT00909, Peroxisome proliferator-activated receptor delta